We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 136

“Off Label” May be On Track
  • Weil Gotshal & Manges LLP
  • USA
  • April 28 2017

In November, we reported on the Food and Drug Administration’s (“FDA”) decision to collect feedback regarding whether drug and device manufacturers


Arizona First to Pass Law Protecting Off-Label Promotion of Approved Drugs
  • Day Pitney LLP
  • USA
  • April 3 2017

Arizona has become the first state to pass legislation allowing pharmaceutical companies to promote off-label uses for approved prescription drugs to


John P. Stigi III
  • Sheppard Mullin Richter & Hampton LLP

Taraneh Fard
  • Sheppard Mullin Richter & Hampton LLP

John C. Paul
  • Finnegan, Henderson, Farabow, Garrett & Dunner LLP

D. Brian Kacedon
  • Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Stephanie A. Kennan
  • McGuireWoods LLP

Kevin S. Ranlett
  • Mayer Brown

Charlie A. Iovino
  • McGuireWoods LLP

Alexis Kellert
  • Weil Gotshal & Manges LLP